Literature DB >> 13620327

Liver disease and antibody formation.

W P HAVENS.   

Abstract

Entities:  

Keywords:  BLOOD PROTEINS; LIVER DISEASES/physiology

Mesh:

Substances:

Year:  1959        PMID: 13620327     DOI: 10.1159/000228506

Source DB:  PubMed          Journal:  Int Arch Allergy Appl Immunol        ISSN: 0020-5915


× No keyword cloud information.
  11 in total

1.  Autoimmune phenomena in alcholic cirrhosis.

Authors:  H H Zinneman
Journal:  Am J Dig Dis       Date:  1975-04

Review 2.  [PATHOGENESIS OF CHRONIC HEPATITIS AS AN IMMUNOLOGICAL PROBLEM].

Authors:  F SCHEIFFARTH; H WARNATZ
Journal:  Klin Wochenschr       Date:  1965-05-01

3.  Horizons in the study of liver disease.

Authors:  F SCHAFFNER; H POPPER
Journal:  Am J Dig Dis       Date:  1960-12

4.  Immunological assessment of mice with chronic jaundice and runting induced by reovirus 3.

Authors:  M L Walters; N F Stanley; R L Dawkins; M P Alpers
Journal:  Br J Exp Pathol       Date:  1973-06

5.  Delayed hypersensitivity in alcoholic cirrhosis.

Authors:  B Straus; M R Berenyi; J M Huang; E Straus
Journal:  Am J Dig Dis       Date:  1971-06

Review 6.  Antibodies and immunoglobulins in liver disease.

Authors:  G Walker; D Doniach
Journal:  Gut       Date:  1968-06       Impact factor: 23.059

7.  The primary immune response to haemocyanin in patients with primary biliary cirrhosis.

Authors:  R A Fox; F J Dudley; S Sherlock
Journal:  Clin Exp Immunol       Date:  1973-08       Impact factor: 4.330

8.  Serum levels of insulin-binding antibodies in diabetic patients treated with monocomponent insulin.

Authors:  A Czyzyk; J Lawecki; H Rogala; E Miedzińska; A Popik-Hankiewicz
Journal:  Diabetologia       Date:  1974-06       Impact factor: 10.122

Review 9.  [Significance of immunologic reactions for the diagnosis and pathogenesis of chronic hepatitis].

Authors:  K Schumacher
Journal:  Klin Wochenschr       Date:  1969-09-15

Review 10.  A theory of the action of cancer chemotherapeutic drugs.

Authors:  S Rose
Journal:  Clin Exp Immunol       Date:  1967-05       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.